Profitability
This table compares Growlife and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Growlife | N/A | N/A | N/A |
| Growlife Competitors | -5.54% | 0.68% | 0.04% |
Earnings & Valuation
This table compares Growlife and its rivals revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Growlife | N/A | -$4.48 million | 0.00 |
| Growlife Competitors | $2.83 billion | $80.45 million | -4.51 |
Growlife’s rivals have higher revenue and earnings than Growlife. Growlife is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.
Insider & Institutional Ownership
Volatility and Risk
Growlife has a beta of 2.3, indicating that its share price is 130% more volatile than the S&P 500. Comparatively, Growlife’s rivals have a beta of 1.22, indicating that their average share price is 22% more volatile than the S&P 500.
Summary
Growlife rivals beat Growlife on 6 of the 9 factors compared.
About Growlife
GrowLife, Inc. focuses on the functional mushroom business. It processes, stores, markets, distributes, and sells fresh and dried mushroom products. The company was founded in 2012 and is headquartered in Kirkland, Washington.
Receive News & Ratings for Growlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Growlife and related companies with MarketBeat.com's FREE daily email newsletter.
